<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/21/brokerages-anticipate-cormedix-inc-nasdaqcrmd-will-announce-quarterly-sales-of-90000-00.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-21T21:42:42+00:00"/>
    <meta property="og:title" content="Brokerages Anticipate CorMedix Inc (NASDAQ:CRMD) Will Announce Quarterly Sales of $90,000.00"/>
    <meta property="og:description" content="Analysts expect that CorMedix Inc (NASDAQ:CRMD) will post $90,000.00 in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for CorMedix’s earnings, with the lowest sales estimate coming in at $20,000.00 and the highest estimate coming in at $150,000.00. CorMedix posted sales of $30,000.00 in the same quarter last […]"/>
  </head>
  <body>
    <article>
      <h1>Brokerages Anticipate CorMedix Inc (NASDAQ:CRMD) Will Announce Quarterly Sales of $90,000.00</h1>
      <address><time datetime="2019-11-21T21:42:42+00:00">21 Nov 2019, 21:42</time> by <a rel="author" href="https://www.thecerbatgem.com/author/amy" target="_blank">Amy Steele</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/generic-stocks.jpg"/>
      </figure>
      <p>Analysts expect that CorMedix Inc (NASDAQ:CRMD) will post $90,000.00 in sales for the current fiscal quarter, <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> reports. Two analysts have provided estimates for CorMedix’s earnings, with the lowest sales estimate coming in at $20,000.00 and the highest estimate coming in at $150,000.00. CorMedix posted sales of $30,000.00 in the same quarter last year, which suggests a positive year-over-year growth rate of 200%. The business is scheduled to issue its next earnings report on Thursday, March 12th.</p>
      <p>On average, analysts expect that CorMedix will report full-year sales of $460,000.00 for the current financial year, with estimates ranging from $430,000.00 to $490,000.00. For the next financial year, analysts forecast that the company will report sales of $12.28 million, with estimates ranging from $9.89 million to $14.67 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow CorMedix.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NASDAQ/CRMD/earnings/">CRMD</a> traded down $0.14 during trading hours on Monday, reaching $6.29. The company’s stock had a trading volume of 195,200 shares, compared to its average volume of 425,092. CorMedix has a 1-year low of $4.86 and a 1-year high of $13.70. The company has a 50 day moving average of $5.79 and a two-hundred day moving average of $7.41.</p>
      <p>
        <b>About CorMedix</b>
      </p>
      <p>CorMedix, Inc, a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology.</p>
      <p>Featured Story: <a href="https://www.marketbeat.com/market-data/most-active-stocks/">What causes a stock to be most active?</a></p>
      <p>
        <a href="https://www.zacks.com/registration/pfp/?ALERT=ZER_LINK&amp;ADID=AMERBMN_CONTENT_ZER&amp;skip_rpt_name_check=skip_rpt_name_check&amp;t=CRMD">Get a free copy of the Zacks research report on CorMedix (CRMD)</a>
      </p>
      <p>For more information about research offerings from Zacks Investment Research, visit <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks.com</a></p>
    </article>
  </body>
</html>